ATA292278A - Verfahren zur herstellung einer verbesserten vakzine gegen newcastle-krankheit - Google Patents

Verfahren zur herstellung einer verbesserten vakzine gegen newcastle-krankheit

Info

Publication number
ATA292278A
ATA292278A AT782922A AT292278A ATA292278A AT A292278 A ATA292278 A AT A292278A AT 782922 A AT782922 A AT 782922A AT 292278 A AT292278 A AT 292278A AT A292278 A ATA292278 A AT A292278A
Authority
AT
Austria
Prior art keywords
producing
vaccine against
newcastle disease
improved vaccine
against newcastle
Prior art date
Application number
AT782922A
Other languages
English (en)
Other versions
AT358166B (de
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Publication of ATA292278A publication Critical patent/ATA292278A/de
Application granted granted Critical
Publication of AT358166B publication Critical patent/AT358166B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT292278A 1977-04-25 1978-04-24 Verfahren zur herstellung einer verbesserten vakzine gegen newcastle-krankheit AT358166B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE853923 1977-04-25

Publications (2)

Publication Number Publication Date
ATA292278A true ATA292278A (de) 1980-01-15
AT358166B AT358166B (de) 1980-08-25

Family

ID=3861522

Family Applications (1)

Application Number Title Priority Date Filing Date
AT292278A AT358166B (de) 1977-04-25 1978-04-24 Verfahren zur herstellung einer verbesserten vakzine gegen newcastle-krankheit

Country Status (22)

Country Link
US (1) US4235876A (de)
AR (1) AR218304A1 (de)
AT (1) AT358166B (de)
BE (1) BE853923A (de)
CA (1) CA1113860A (de)
CH (1) CH641047A5 (de)
DE (1) DE2817891A1 (de)
DK (1) DK160878A (de)
FI (1) FI59535C (de)
FR (1) FR2388564A1 (de)
GB (1) GB1593567A (de)
HU (1) HU179290B (de)
IE (1) IE46943B1 (de)
IL (1) IL54390A (de)
IT (1) IT1113070B (de)
LU (1) LU79508A1 (de)
NL (1) NL7804182A (de)
NO (1) NO153010C (de)
PH (1) PH14085A (de)
PT (1) PT67868B (de)
SE (1) SE430752B (de)
ZA (1) ZA781832B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
US5118502A (en) * 1989-06-20 1992-06-02 The University Of Georgia Research Foundation, Inc. Naturally attenuated newcastle disease vaccine and method of using the same
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.
US5686077A (en) * 1991-09-20 1997-11-11 Akzo Nobel N.V. Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)
ES2188593T3 (es) * 1992-03-24 2003-07-01 United Cancer Res Inst Vacuna que contiene un virus vivo.
US5427791A (en) * 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
CA2181862C (en) * 1995-08-01 2009-12-22 Carla Christina Schrier Mild newcastle disease virus vaccine
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
HUP0202537A3 (en) 1999-08-24 2004-05-28 Teva Pharma A vaccine composition and method of using the same
KR101481164B1 (ko) * 2008-01-30 2015-01-09 주식회사 미래셀바이오 체세포 유래 다능성 줄기세포의 제조 방법
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
US9956281B2 (en) 2011-05-04 2018-05-01 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767117A (en) * 1953-10-22 1956-10-16 Crawley John Frederick Poultry virus vaccine products and method of preparing the same
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
US3548054A (en) * 1969-06-06 1970-12-15 Lilly Co Eli Method for improving weight gains and reducing gross lesions in chickens exposed to marek's disease
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines

Also Published As

Publication number Publication date
IT7822203A0 (it) 1978-04-11
NO781421L (no) 1978-10-26
PH14085A (en) 1981-02-10
FR2388564A1 (fr) 1978-11-24
CA1113860A (en) 1981-12-08
DK160878A (da) 1978-10-26
IE46943B1 (en) 1983-11-16
FI781233A (fi) 1978-10-26
FR2388564B1 (de) 1980-07-25
IL54390A (en) 1980-11-30
NO153010B (no) 1985-09-23
ZA781832B (en) 1979-03-28
NL7804182A (nl) 1978-10-27
HU179290B (en) 1982-09-28
IL54390A0 (en) 1978-06-15
LU79508A1 (fr) 1978-09-29
AR218304A1 (es) 1980-05-30
BE853923A (fr) 1977-10-25
SE430752B (sv) 1983-12-12
SE7804116L (sv) 1978-10-26
PT67868B (en) 1979-10-10
CH641047A5 (en) 1984-02-15
FI59535B (fi) 1981-05-29
GB1593567A (en) 1981-07-22
IT1113070B (it) 1986-01-20
FI59535C (fi) 1981-09-10
NO153010C (no) 1986-01-02
US4235876A (en) 1980-11-25
DE2817891A1 (de) 1978-11-09
IE780811L (en) 1978-10-25
AT358166B (de) 1980-08-25
PT67868A (en) 1978-05-01

Similar Documents

Publication Publication Date Title
AT362082B (de) Verfahren zur herstellung eines desinfektions- mittels
AT358166B (de) Verfahren zur herstellung einer verbesserten vakzine gegen newcastle-krankheit
ATA220178A (de) Verfahren zur herstellung einer waesserigen installationzubereitung
LU79235A1 (de) Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern
AT370115B (de) Verfahren zur herstellung einer waesserigen kunststoffdispersion
AT362496B (de) Verfahren zur herstellung einer tollwut-vaccine
AT367772B (de) Verfahren zur herstellung eines 6alpha-halogen -pregnadien-derivates
AT367985B (de) Verfahren zur herstellung getrennter reissverschluesse
ATA151278A (de) Verfahren zur herstellung einer tontaube
ATA246978A (de) Verfahren zur herstellung weitgehend monomerer methylveraetherter methylolmelamine
DD134079A5 (de) Verfahren zur herstellung eines baukoerpers
AT368390B (de) Verfahren zur herstellung einer heterovakzine
AT356642B (de) Verfahren zur herstellung von acylcyaniden
AT347440B (de) Verfahren zur herstellung von benzoylcyanid
ATA328780A (de) Verfahren zur herstellung acylaminobenzoesaeurecerivaten
AT360500B (de) Verfahren zur herstellung neuer, halogenierter buttersaeurechloride
DD138506A1 (de) Verfahren zur herstellung einer waessrigen loesung
AT362648B (de) Verfahren zur herstellung von huellen doppelter kruemmung
AT366109B (de) Verfahren zur herstellung hydrophiler acrylfasern
AT360998B (de) Verfahren zur herstellung neuer n-pyrimidinyl- -imidsaeureester
AT352104B (de) Verfahren zur herstellung von n-cyanoalkyl-p- halogenphenoxy-isobutyramiden
AT369989B (de) Verfahren zur herstellung einer kombinationsvaccine
AT351160B (de) Verfahren zur herstellung einer abgeschwaechten influenzavirusvakzine
AT359513B (de) Verfahren zur herstellung fluorierter s-triazine
DD132073A1 (de) Verfahren zur herstellung lebendiger mumps-vakzine

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee